CCI approves Sequent Scientific's merger with nine entities

The Competition Commission of India (CCI) has approved the merger of Sequent Scientific with nine of its entities, which will help streamline operations and improve its market efficiency. The merger, aimed at creating a stronger entity, will facilitate the company’s growth, enabling it to better serve its clients and expand its footprint. This approval comes after an in-depth examination of the merger's potential impact on competition in the pharmaceutical and animal healthcare sectors. Sequent Scientific, a prominent player in animal health, will continue to focus on delivering innovative solutions to the market while benefiting from a more integrated and efficient structure post-merger.